[4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate

C53H52N16O13P2S2 — CID 170936657

IUPAC[4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate
SMILESCC(=O)N1Cc2ccccc2-c2c(nnn2CCOc2ccc(C(=O)Oc3ccc(CS[P@]4(=O)N[C@H]5[C@@H](O)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(O)(=S)N[C@@H]5[C@@H](O)[C@H](n6cnc7c(N)ncnc76)O[C@@H]5CO4)cc3)cc2)-c2ccccc21
InChIInChI=1S/C53H52N16O13P2S2/c1-27(70)66-20-30-6-2-3-7-33(30)43-38(34-8-4-5-9-35(34)66)62-65-69(43)18-19-77-31-16-12-29(13-17-31)52(74)80-32-14-10-28(11-15-32)23-86-84(76)64-40-36(81-51(45(40)72)68-26-59-42-48(68)60-53(55)61-49(42)73)21-78-83(75,85)63-39-37(22-79-84)82-50(44(39)71)67-25-58-41-46(54)56-24-57-47(41)67/h2-17,24-26,36-37,39-40,44-45,50-51,71-72H,18-23H2,1H3,(H,64,76)(H2,54,56,57)(H2,63,75,85)(H3,55,60,61,73)/t36-,37-,39+,40-,44-,45-,50-,51-,83?,84+/m1/s1
InChIKeyRQAHPFXSMFSRPS-AXOFLUBOSA-N
MW1247.18 g/mol
LogP3.95
Rot. Bonds11

About [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate

[4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate (PubChem CID 170936657) has the molecular formula C53H52N16O13P2S2 and a molecular weight of 1247.18 g/mol. Its IUPAC name is [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate.

Molecular Properties

Compound Name[4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate
PubChem CID170936657
Molecular FormulaC53H52N16O13P2S2
Molecular Weight1247.18 g/mol
Exact Mass1246.28
IUPAC Name[4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate
SMILESCC(=O)N1Cc2ccccc2-c2c(nnn2CCOc2ccc(C(=O)Oc3ccc(CS[P@]4(=O)N[C@H]5[C@@H](O)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(O)(=S)N[C@@H]5[C@@H](O)[C@H](n6cnc7c(N)ncnc76)O[C@@H]5CO4)cc3)cc2)-c2ccccc21
InChIInChI=1S/C53H52N16O13P2S2/c1-27(70)66-20-30-6-2-3-7-33(30)43-38(34-8-4-5-9-35(34)66)62-65-69(43)18-19-77-31-16-12-29(13-17-31)52(74)80-32-14-10-28(11-15-32)23-86-84(76)64-40-36(81-51(45(40)72)68-26-59-42-48(68)60-53(55)61-49(42)73)21-78-83(75,85)63-39-37(22-79-84)82-50(44(39)71)67-25-58-41-46(54)56-24-57-47(41)67/h2-17,24-26,36-37,39-40,44-45,50-51,71-72H,18-23H2,1H3,(H,64,76)(H2,54,56,57)(H2,63,75,85)(H3,55,60,61,73)/t36-,37-,39+,40-,44-,45-,50-,51-,83?,84+/m1/s1
InChIKeyRQAHPFXSMFSRPS-AXOFLUBOSA-N
XLogP3.95
TPSA384.50 Ų
H-Bond Donors8
H-Bond Acceptors26
Rotatable Bonds11
Heavy Atoms86
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001247.18
LogP ≤ 53.95
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phenol_ester', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate?
The IUPAC name of [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate (CID 170936657) is [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate.
What is the SMILES notation for [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate?
The canonical SMILES for [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate is CC(=O)N1Cc2ccccc2-c2c(nnn2CCOc2ccc(C(=O)Oc3ccc(CS[P@]4(=O)N[C@H]5[C@@H](O)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(O)(=S)N[C@@H]5[C@@H](O)[C@H](n6cnc7c(N)ncnc76)O[C@@H]5CO4)cc3)cc2)-c2ccccc21.
What is the InChIKey of [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate?
The InChIKey is RQAHPFXSMFSRPS-AXOFLUBOSA-N. The full InChI is InChI=1S/C53H52N16O13P2S2/c1-27(70)66-20-30-6-2-3-7-33(30)43-38(34-8-4-5-9-35(34)66)62-65-69(43)18-19-77-31-16-12-29(13-17-31)52(74)80-32-14-10-28(11-15-32)23-86-84(76)64-40-36(81-51(45(40)72)68-26-59-42-48(68)60-53(55)61-49(42)73)21-78-83(75,85)63-39-37(22-79-84)82-50(44(39)71)67-25-58-41-46(54)56-24-57-47(41)67/h2-17,24-26,36-37,39-40,44-45,50-51,71-72H,18-23H2,1H3,(H,64,76)(H2,54,56,57)(H2,63,75,85)(H3,55,60,61,73)/t36-,37-,39+,40-,44-,45-,50-,51-,83?,84+/m1/s1.
What are the key properties of [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate?
[4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate has a molecular weight of 1247.18 g/mol, XLogP of 3.95, 11 rotatable bonds, 8 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[(1S,3S,6S,8R,9R,10R,15S,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-8-(6-aminopurin-9-yl)-9,12,18-trihydroxy-3-oxo-12-sulfanylidene-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]phenyl] 4-[2-(13-acetyl-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-3-yl)ethoxy]benzoate is sourced from PubChem (CID 170936657), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).